Logo image of QIA.DE

QIAGEN N.V. (QIA.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:QIA - NL0015002CX3 - Common Stock

41.29 EUR
-1.07 (-2.53%)
Last: 1/8/2026, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, QIA scores 6 out of 10 in our fundamental rating. QIA was compared to 22 industry peers in the Life Sciences Tools & Services industry. QIA has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. QIA has a correct valuation and a medium growth rate. This makes QIA very considerable for quality investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year QIA was profitable.
QIA had a positive operating cash flow in the past year.
Each year in the past 5 years QIA has been profitable.
QIA had a positive operating cash flow in each of the past 5 years.
QIA.DE Yearly Net Income VS EBIT VS OCF VS FCFQIA.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

The Return On Assets of QIA (6.19%) is better than 68.18% of its industry peers.
The Return On Equity of QIA (11.11%) is better than 72.73% of its industry peers.
Looking at the Return On Invested Capital, with a value of 7.44%, QIA is in the better half of the industry, outperforming 63.64% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for QIA is below the industry average of 9.70%.
The 3 year average ROIC (7.25%) for QIA is below the current ROIC(7.44%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROIC 7.44%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
QIA.DE Yearly ROA, ROE, ROICQIA.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

QIA's Profit Margin of 19.58% is amongst the best of the industry. QIA outperforms 90.91% of its industry peers.
In the last couple of years the Profit Margin of QIA has declined.
QIA's Operating Margin of 27.02% is amongst the best of the industry. QIA outperforms 95.45% of its industry peers.
In the last couple of years the Operating Margin of QIA has grown nicely.
With an excellent Gross Margin value of 64.10%, QIA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
QIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
QIA.DE Yearly Profit, Operating, Gross MarginsQIA.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so QIA is destroying value.
The number of shares outstanding for QIA has been reduced compared to 1 year ago.
The number of shares outstanding for QIA has been reduced compared to 5 years ago.
The debt/assets ratio for QIA has been reduced compared to a year ago.
QIA.DE Yearly Shares OutstandingQIA.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
QIA.DE Yearly Total Debt VS Total AssetsQIA.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 3.56 indicates that QIA is not in any danger for bankruptcy at the moment.
QIA has a better Altman-Z score (3.56) than 63.64% of its industry peers.
The Debt to FCF ratio of QIA is 4.50, which is a neutral value as it means it would take QIA, 4.50 years of fcf income to pay off all of its debts.
QIA's Debt to FCF ratio of 4.50 is fine compared to the rest of the industry. QIA outperforms 72.73% of its industry peers.
A Debt/Equity ratio of 0.45 indicates that QIA is not too dependend on debt financing.
The Debt to Equity ratio of QIA (0.45) is better than 68.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Altman-Z 3.56
ROIC/WACC0.89
WACC8.36%
QIA.DE Yearly LT Debt VS Equity VS FCFQIA.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

QIA has a Current Ratio of 2.60. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 2.60, QIA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
QIA has a Quick Ratio of 2.30. This indicates that QIA is financially healthy and has no problem in meeting its short term obligations.
QIA has a Quick ratio of 2.30. This is amongst the best in the industry. QIA outperforms 90.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.6
Quick Ratio 2.3
QIA.DE Yearly Current Assets VS Current LiabilitesQIA.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

5

3. Growth

3.1 Past

QIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.18%, which is quite good.
QIA shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.92% yearly.
The Revenue has been growing slightly by 5.32% in the past year.
The Revenue has been growing slightly by 5.32% on average over the past years.
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%

3.2 Future

Based on estimates for the next years, QIA will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.41% on average per year.
The Revenue is expected to grow by 7.12% on average over the next years.
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
QIA.DE Yearly Revenue VS EstimatesQIA.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
QIA.DE Yearly EPS VS EstimatesQIA.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.34 indicates a rather expensive valuation of QIA.
77.27% of the companies in the same industry are more expensive than QIA, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.00. QIA is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 18.62 indicates a rather expensive valuation of QIA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 77.27% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.70, QIA is valued a bit cheaper.
Industry RankSector Rank
PE 20.34
Fwd PE 18.62
QIA.DE Price Earnings VS Forward Price EarningsQIA.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of QIA indicates a somewhat cheap valuation: QIA is cheaper than 72.73% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of QIA indicates a rather cheap valuation: QIA is cheaper than 81.82% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 22.14
EV/EBITDA 13.74
QIA.DE Per share dataQIA.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The decent profitability rating of QIA may justify a higher PE ratio.
PEG (NY)2.62
PEG (5Y)2.57
EPS Next 2Y7.68%
EPS Next 3Y8.33%

2

5. Dividend

5.1 Amount

QIA has a yearly dividend return of 0.56%, which is pretty low.
QIA's Dividend Yield is a higher than the industry average which is at 0.48.
Compared to an average S&P500 Dividend Yield of 1.94, QIA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.56%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y7.68%
EPS Next 3Y8.33%
QIA.DE Yearly Income VS Free CF VS DividendQIA.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

QIAGEN N.V.

FRA:QIA (1/8/2026, 7:00:00 PM)

41.29

-1.07 (-2.53%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)11-04 2025-11-04/dmh
Earnings (Next)02-03 2026-02-03/amc
Inst Owners85.46%
Inst Owner ChangeN/A
Ins Owners0.44%
Ins Owner ChangeN/A
Market Cap8.95B
Revenue(TTM)2.07B
Net Income(TTM)405.37M
Analysts74.17
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.56%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.14%
Min EPS beat(2)-2.4%
Max EPS beat(2)2.11%
EPS beat(4)2
Avg EPS beat(4)0.92%
Min EPS beat(4)-3.85%
Max EPS beat(4)7.8%
EPS beat(8)5
Avg EPS beat(8)1.59%
EPS beat(12)8
Avg EPS beat(12)2.59%
EPS beat(16)12
Avg EPS beat(16)5.18%
Revenue beat(2)0
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-0.72%
Max Revenue beat(2)-0.12%
Revenue beat(4)1
Avg Revenue beat(4)-0.33%
Min Revenue beat(4)-1.92%
Max Revenue beat(4)1.43%
Revenue beat(8)1
Avg Revenue beat(8)-0.6%
Revenue beat(12)2
Avg Revenue beat(12)-0.64%
Revenue beat(16)6
Avg Revenue beat(16)0.46%
PT rev (1m)-0.31%
PT rev (3m)-0.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.96%
EPS NY rev (1m)-0.77%
EPS NY rev (3m)-0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.91%
Revenue NY rev (1m)-0.05%
Revenue NY rev (3m)-0.28%
Valuation
Industry RankSector Rank
PE 20.34
Fwd PE 18.62
P/S 5.05
P/FCF 22.14
P/OCF 15.91
P/B 2.87
P/tB 13.11
EV/EBITDA 13.74
EPS(TTM)2.03
EY4.92%
EPS(NY)2.22
Fwd EY5.37%
FCF(TTM)1.86
FCFY4.52%
OCF(TTM)2.6
OCFY6.29%
SpS8.17
BVpS14.4
TBVpS3.15
PEG (NY)2.62
PEG (5Y)2.57
Graham Number25.65
Profitability
Industry RankSector Rank
ROA 6.19%
ROE 11.11%
ROCE 10.03%
ROIC 7.44%
ROICexc 10.67%
ROICexgc 39.98%
OM 27.02%
PM (TTM) 19.58%
GM 64.1%
FCFM 22.82%
ROA(3y)4.59%
ROA(5y)5.65%
ROE(3y)7.84%
ROE(5y)10.58%
ROIC(3y)7.25%
ROIC(5y)7.96%
ROICexc(3y)9.42%
ROICexc(5y)10.13%
ROICexgc(3y)34.6%
ROICexgc(5y)42.77%
ROCE(3y)9.77%
ROCE(5y)10.73%
ROICexgc growth 3Y-31.24%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-13.09%
ROICexc growth 5Y6.48%
OM growth 3Y-5.04%
OM growth 5Y4.09%
PM growth 3Y-42.96%
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y-0.63%
F-Score8
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 4.5
Debt/EBITDA 2.17
Cap/Depr 97.52%
Cap/Sales 8.94%
Interest Coverage 250
Cash Conversion 87.76%
Profit Quality 116.56%
Current Ratio 2.6
Quick Ratio 2.3
Altman-Z 3.56
F-Score8
WACC8.36%
ROIC/WACC0.89
Cap/Depr(3y)78.4%
Cap/Depr(5y)95.94%
Cap/Sales(3y)7.97%
Cap/Sales(5y)9.87%
Profit Quality(3y)273.85%
Profit Quality(5y)189.74%
High Growth Momentum
Growth
EPS 1Y (TTM)8.18%
EPS 3Y-7.35%
EPS 5Y7.92%
EPS Q2Q%4.04%
EPS Next Y7.77%
EPS Next 2Y7.68%
EPS Next 3Y8.33%
EPS Next 5Y9.41%
Revenue 1Y (TTM)5.32%
Revenue growth 3Y-4.22%
Revenue growth 5Y5.32%
Sales Q2Q%6.09%
Revenue Next Year4.96%
Revenue Next 2Y5.54%
Revenue Next 3Y5.79%
Revenue Next 5Y7.12%
EBIT growth 1Y18.55%
EBIT growth 3Y-9.05%
EBIT growth 5Y9.63%
EBIT Next Year57.21%
EBIT Next 3Y22.16%
EBIT Next 5Y15.78%
FCF growth 1Y71.67%
FCF growth 3Y5.12%
FCF growth 5Y55.1%
OCF growth 1Y52.1%
OCF growth 3Y1.77%
OCF growth 5Y15.28%

QIAGEN N.V. / QIA.DE FAQ

What is the fundamental rating for QIA stock?

ChartMill assigns a fundamental rating of 6 / 10 to QIA.DE.


Can you provide the valuation status for QIAGEN N.V.?

ChartMill assigns a valuation rating of 5 / 10 to QIAGEN N.V. (QIA.DE). This can be considered as Fairly Valued.


How profitable is QIAGEN N.V. (QIA.DE) stock?

QIAGEN N.V. (QIA.DE) has a profitability rating of 7 / 10.


What is the financial health of QIAGEN N.V. (QIA.DE) stock?

The financial health rating of QIAGEN N.V. (QIA.DE) is 8 / 10.


Can you provide the expected EPS growth for QIA stock?

The Earnings per Share (EPS) of QIAGEN N.V. (QIA.DE) is expected to grow by 7.77% in the next year.